Breast and Cervical Cancer Early Detection and Control Advisory Committee, 20754-20755 [05-7992]
Download as PDF
<![CDATA[
20754
Federal Register / Vol. 70, No. 76 / Thursday, April 21, 2005 / Notices
Intermediaries, Federal Maritime
Commission, Washington, DC 20573.
Non-Vessel—Operating Common Carrier
Ocean Transportation Intermediary
Applicants:
Regal Shipping Inc. dba Sealines
International dba Shipping Line,
333 Southern Blvd., Suite 404, West
Palm Beach, FL 33405. Officer:
Edward T. Nevins, President
(Qualifying Individual).
Inter-Continental Trading, Inc. dba
Yuan Mao Logistics dba InterContinental Trading Group, Inc.,
1224 Santa Anita Avenue, #F,
South El Monte, CA 91733. Officers:
Shun Li, Secretary (Qualifying
Individual), Cheng Zhou, Zhou,
President.
Non-Vessel-Operating Common Carrier
and Ocean Freight Forwarder
Transportation Intermediary
Applicants:
Interport Freight Services, Inc., 370
McClellan Highway, East Boston,
MA 02128. Officer: Joseph D’Urso,
President (Qualifying Individual).
Sea Shipping Line (California) Inc.,
9401 San Leandro Street, Oakland,
CA 94683. Officers: Frank
Rosenberg, President (Qualifying
Individual), Fred Morgenthaler,
Secretary.
Ocean Freight Forwarder—Ocean
Transportation Intermediary
Applicants:
UCB Logistics, Inc., 5777 W. Century
Blvd., Suite 590, Los Angeles, CA
90045. Officers: Robert A. Carranza,
Vice President (Qualifying
Individual), Young S. Chang,
President.
Traffich Tech International, US, LLC,
Crystal Plaza One, 2001 Jefferson
Davis Highway, Suite 1111,
Arlington, VA 22202. Officer: Collin
Anday, Director (Qualifying
Individual).
Dated: April 15, 2005.
Bryant L. VanBrakle,
Secretary.
[FR Doc. 05–7956 Filed 4–20–05; 8:45 am]
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
Web site at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than May 13, 2005.
A. Federal Reserve Bank of Atlanta
(Andre Anderson, Vice President) 1000
Peachtree Street, NE., Atlanta, Georgia
30303:
1. Tombigbee Bancshares, Inc., Sweet
Water, Alabama; to become a bank
holding company by acquiring 100
percent of the voting shares of Sweet
Water State Bank, Sweet Water,
Alabama.
Board of Governors of the Federal Reserve
System, April 15, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–7980 Filed 4–20–05; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 6730–01–P
Centers for Disease Control and
Prevention
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Healthcare Infection Control Practices
Advisory Committee: Notice of Charter
Renewal
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Healthcare Infection Control Practices
Advisory Committee, Centers for
Disease Control and Prevention, of the
Department of Health and Human
Services, has been renewed for a 2-year
VerDate jul<14>2003
14:55 Apr 20, 2005
Jkt 205001
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
period extending through January 19,
2007.
For Further Information Contact:
Michele Pearson, M.D., Executive
Secretary, Healthcare Infection Control
Practices Advisory Committee, Centers
for Disease Control and Prevention, of
the Department of Health and Human
Services, 1600 Clifton Road, NE., M/S
E–68, Atlanta, Georgia 30333, telephone
404–498–1266 or fax 404–498–1244.
The Director, Management and
Analysis and Services office has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: April 14, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–7993 Filed 4–20–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Breast and Cervical Cancer Early
Detection and Control Advisory
Committee
In accordance with section 10(a)(2)of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting:
Name: Breast and Cervical Cancer Early
Detection and Control Advisory Committee
(BCCEDCAC).
Times and Dates: 8:30 a.m.–5 p.m., May 3,
2005. 8:30 a.m.–3 p.m., May 4, 2005.
Place: Omni CNN Center Hotel, 100 CNN
Center, Atlanta, Georgia, 30303 Phone: 404–
659–0000.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Secretary, Department of Health
and Human Services, and the Director, CDC,
regarding the early detection and control of
breast and cervical cancer. The committee
makes recommendations regarding national
program goals and objectives;
implementation strategies; and program
priorities including surveillance,
epidemiologic investigations, education and
training, information dissemination,
professional interactions and collaborations,
and policy.
Matters To Be Discussed: The agenda will
include discussion and review of National
Cancer Prevention and Control Program
E:\FR\FM\21APN1.SGM
21APN1
Federal Register / Vol. 70, No. 76 / Thursday, April 21, 2005 / Notices
Highlights; overview of USCS Report; update
of the National Report; update of expert
panel meetings; Performance based
budgeting; providing Mammography
Screening for younger Women; getting the
facts on Tribal & Territories NBCCEDP
Program; using data to drive program
planning; serving American Indian
Populations; Coalition; Partnership &
Collaboration; Survivorship; Case
Management Evaluation.
Agenda items are subject to change as
priorities dictate.
For More Information Contact: Debra
Younginer, Executive Secretary, BCCEDCAC,
Division of Cancer Prevention and Control,
National Center for Chronic Disease
Prevention and Health Promotion, CDC, 4770
Buford Highway, Mailstop K–57, Chamblee,
Georgia 30316, Telephone: 770–488–1074.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 15, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–7992 Filed 4–20–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control Initial Review Group
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers For
Disease Control and Prevention (CDC)
announce the following meeting:
Name: National Center for Injury
Prevention and Control (NCIPC), Initial
Review Group (IRG).
Time and Date: 1 p.m.–5 p.m., May 20,
2005.
Place: The conference call will originate at
the National Center for Injury Prevention and
Control, in Atlanta, Georgia.
Status: Closed: 1 p.m.–5 p.m., May 20,
2005.
Purpose: This group is charged with
providing advice and guidance to the
Secretary of Health and Human Services and
the Director, CDC, concerning the scientific
and technical merit of grant and cooperative
agreement applications received from
academic institutions and other public and
private profit and nonprofit organizations,
including State and local government
agencies, to conduct specific injury research
that focuses on prevention and control and
supports Injury Control Research Centers
(ICRCs).
VerDate jul<14>2003
14:55 Apr 20, 2005
Jkt 205001
Matters to be Discussed: Agenda items
include an overview of the injury program,
discussion of the review process and
panelists’ responsibilities, and the review of
and vote on applications. From 1 p.m. to 5
p.m., May 20, the Group will review
individual research cooperative agreement in
response to announcements: #05098,
Research in Areas of Acute Care, Disability,
and Rehabilitation at the Notre Dame Center
for Orthopedic Research and Engineering;
#05099, University of Oklahoma Health
Sciences Center, Developmental Injury
Prevention Research Center; #05100,
National Foundation for Trauma Care: The
Study of the Impact of a Terrorist Attack on
Individual Trauma Centers; #05101,
Pennsylvania Chapter of the American
College of Emergency Physicians; #05106,
Iowa State University, Center for the Study
of Violence. This meeting will be closed to
the public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Pub. L. 92–463.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D., M.S.E.H.,
Executive Secretary, NCIPC IRG, CDC, 4770
Buford Highway, NE., M/S K02, Atlanta,
Georgia 30341–3724, telephone (770) 488–
4655.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and Prevention and the Agency for
Toxic Substances and Disease Registry.
Dated: April 15, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–7995 Filed 4–20–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control Initial Review Group
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting:
Name: National Center for Injury
Prevention and Control (NCIPC), Initial
Review Group (IRG).
Times and Dates: 12:30 p.m.–5:30 p.m.,
May 18, 2005. 12:30 p.m.–5:30 p.m., May 19,
2005.
Place: The conference call will originate at
the National Center for Injury Prevention and
Control, in Atlanta, Georgia.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
20755
Status: Closed: 12:30 p.m.–5:30 p.m., May
18, 2005.
Closed: 12:30 p.m.–5:30 p.m., May 19,
2005.
Purpose: This group is charged with
providing advice and guidance to the
Secretary of Health and Human Services and
the Director, CDC, concerning the scientific
and technical merit of grant and cooperative
agreement applications received from
academic institutions and other public and
private profit and nonprofit organizations,
including State and local government
agencies, to conduct specific injury research
that focuses on prevention and control and
supports Injury Control Research Centers
(ICRCs).
Matters to be Discussed: Agenda items
include an overview of the injury program,
discussion of the review process and
panelists’ responsibilities, and the review of
and vote on applications. Beginning at 12:30
p.m., May 18, through 5:30 p.m., May 19, the
Group will review individual research
cooperative agreement in response to
announcement: #05020, Youth Violence
through Community-Level Change. This
meeting will be closed to the public in
accordance with provisions set forth in
section 552b(c)(4) and (6), title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Pub. L. 92–463.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact:
Gwendolyn H. Cattledge, Ph.D., M.S.E.H.,
Executive Secretary, NCIPC IRG, CDC, 4770
Buford Highway, NE., M/S K02, Atlanta,
Georgia 30341–3724, telephone 770–488–
4655.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and Prevention and the Agency for
Toxic Substances and Disease Registry.
Dated: April 15, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–7989 Filed 4–20–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health Advisory Board on
Radiation and Worker Health
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting:
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 70, Number 76 (Thursday, April 21, 2005)]
[Notices]
[Pages 20754-20755]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7992]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Breast and Cervical Cancer Early Detection and Control Advisory
Committee
In accordance with section 10(a)(2)of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting:
Name: Breast and Cervical Cancer Early Detection and Control
Advisory Committee (BCCEDCAC).
Times and Dates: 8:30 a.m.-5 p.m., May 3, 2005. 8:30 a.m.-3
p.m., May 4, 2005.
Place: Omni CNN Center Hotel, 100 CNN Center, Atlanta, Georgia,
30303 Phone: 404-659-0000.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Secretary,
Department of Health and Human Services, and the Director, CDC,
regarding the early detection and control of breast and cervical
cancer. The committee makes recommendations regarding national
program goals and objectives; implementation strategies; and program
priorities including surveillance, epidemiologic investigations,
education and training, information dissemination, professional
interactions and collaborations, and policy.
Matters To Be Discussed: The agenda will include discussion and
review of National Cancer Prevention and Control Program
[[Page 20755]]
Highlights; overview of USCS Report; update of the National Report;
update of expert panel meetings; Performance based budgeting;
providing Mammography Screening for younger Women; getting the facts
on Tribal & Territories NBCCEDP Program; using data to drive program
planning; serving American Indian Populations; Coalition;
Partnership & Collaboration; Survivorship; Case Management
Evaluation.
Agenda items are subject to change as priorities dictate.
For More Information Contact: Debra Younginer, Executive
Secretary, BCCEDCAC, Division of Cancer Prevention and Control,
National Center for Chronic Disease Prevention and Health Promotion,
CDC, 4770 Buford Highway, Mailstop K-57, Chamblee, Georgia 30316,
Telephone: 770-488-1074.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: April 15, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-7992 Filed 4-20-05; 8:45 am]
BILLING CODE 4163-18-P
